Search Results 1111-1120 of 16246 for monoclonal antibody

1. Autoimmune encephalitis - Center for Multiple Sclerosis and Autoimmune Neurology - Mayo Clinic Research

   Detecting the novel antibody biomarkers for autoimmune encephalitis and developing high-throughput diagnostic methodologies. Some of these antibodies are ...

2. Hepatitis a and hepatitis b vaccine (intramuscular route) - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Hepatitis A is a serious disease of the liver that ...

3. A Study of the Relationship Between Infliximab Levels and the Rate of Colectomies in Patients who have Ulcerative Colitis - Mayo Clinic

   More information. Publications. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms. Ordás I. Ingrid; Mould ...

4. Mayo Clinic Q&A podcast: Herd immunity, antibodies and COVID-19

   The concept of herd immunity has sparked debate about whether it would control the spread of COVID-19. Herd immunity happens when a sufficient proportion of ...

5. A Study to Evaluate Effectiveness and Quality of Life Outcomes of Daratumumab in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Patients with history of prior daratumumab or another anti-CD38 monoclonal antibody treatment who were not refractory or intolerant to such therapy will be able ...

6. Immune globulin (intramuscular route, intravenous route, subcutaneous route) - Mayo Clinic

   Immune globulin contains antibodies that make your immune system stronger. It is used for patients who have primary humoral immunodeficiency (PI) ...

7. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   ... monoclonal antibody (MetMAb); prior antibody therapy such as bevacizumab or cetuximab is allowed with a washout period depending on dosing interval and ...

8. A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma - Mayo Clinic

   Must have relapsed after or failed to respond to at least 2 prior lines of treatment, including one anti-CD20 monoclonal antibody (mAb) and a Bruton's tyrosine ...

9. Overview - T Cell Engineering Laboratory - Mayo Clinic Research

   A chimeric antigen receptor is a synthetic antibody on the surface of T cells that enables T cells to recognize cancer cells. The most successful CAR -T ...

10. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

    Participation eligibility · Subjects who are hepatitis B core antibody (anti-HBc) positive and who are surface antigen negative will need to have a negative ...